NBY 13G

Company

NovaBay Pharmaceuticals, Inc.

Filed

February 4, 2022

Accession Number

0001393825-22-000071

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →